BSECompany Update6d ago · 9 Oct 2026, 03:59 pm
Kindly refer the attachment.
Alivus Life Sciences Ltd · 543322
✦ AI Summary▼ NegativeRegulatory
Alivus Life Sciences Ltd has received an order from the Central Goods & Service Tax Department for FY 2020-21 and FY 2021-22, with an amount of Rs. 25,61,400, along with penalty and interest. The company will assess the impact and may appeal the order.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern3/10
Regulatory Risk8/10
Balance Sheet Risk1/10
Liquidity Impact6/10
Market Sentiment4/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alivus Life Sciences Ltd - 543322 - Announcement Under Regulation 30 Of SEBI (LODR), 2015
Attachments (1)
📄pdf
Download →
105fb1b7-89b1-44f9-ab78-33cda4b85c0e.pdf
View document text
October 9, 2026
To, To,
Dy. General Manager The Manager – Listing,
Department of Corporate Services, National Stock Exchange of India Ltd.,
BSE Ltd., Plot No. C/1, G Block,
P. J. Towers, Dalal Street, Bandra Kurla Complex,
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Ref: Scrip Code: 543322 Ref: Scrip Name: ALIVUS
Dear Sir/Madam,
Subject: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended (“SEBI Listing
Regulations”)
Pursuant to Regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015 (LODR Regulations) read with clause 20 of Para A of
Part A of Schedule III of the LODR Regulations, the details of Intimation/Order received by the
Company from Central Goods & Service Tax Department, Office of the Assistant Commissioner,
Division-VIII, Ankleshwar, Vadodara-II Commissionerate is enclosed herewith as Annexure A.
We request you to take the information on your records.
Thanking You,
Your Sincerely,
For Alivus Life Sciences Limited
(formerly Glenmark Life Sciences Limited)
Rudalf Corriea
Company Secretary & Compliance Officer
Encl.: as above
Alivus Life Sciences Limited ( formerly Glenmark Life Sciences Limited )
Corporate Office: Registered Office:
Technopolis Knowledge Park, A wingO, ffice No. 401 to 407, Plot No 170-172, Chandramouli Industrial Estate
4th Floor, Mahakali Caves Road, Andheri ( E), Mumba–i 400093 Mohol Bazarpeth, Solapur 413 213, India
T: +91 22 6829 7979 | CIN: L74900PN2011PLC139963 | E: complianceofficer@alivus.com | W: www.alivus.com
Annexure A
Particulars Details
Name of the authority. Central Goods & Service Tax Department, Office of the
Assistant Commissioner, Division-VIII, Ankleshwar,
Vadodara-II Commissionerate.
Nature and details of the Order dated 8th October 2026 passed under Section 74(1) of
action(s) taken, or order(s) the CGST Act, 2017.
passed.
Date of receipt of direction or 8th October 2026 around 6.00 pm
order, including any ad-interim
or interim orders, or any other
communication from the
authority.
Details of the violation(s) Order u/s 74(1) of the CGST Act, 2017 has been issued by the
/contravention(s) committed or Central Goods & Service Tax Department for FY 2020-21 and
alleged to be committed. FY 2021-22. Amount involved Rs. 25,61,400, along with
penalty amounting to Rs. 25,61,400 and applicable interest.
Impact on financial, operation or There is no material impact on financial, no impact on
other activities of the listed operations or other activities of the Company due to the
entity, quantifiable in monetary intimation of tax payable. This Order is currently appealable
terms to the extent possible. & the Company will make an assessment to exercise the
right to appeal.